Literature DB >> 2753069

Hepatic extraction of morphine is impaired in cirrhosis.

B Crotty1, K J Watson, P V Desmond, M L Mashford, L J Wood, J Colman, F J Dudley.   

Abstract

Using hepatic vein catheterization this study has provided the first direct measurement of morphine hepatic extraction in 8 controls and 8 cirrhotics. The extraction ratio was 0.52 in the control group and was reduced by 25% in the cirrhotics. This reduction is due to impaired enzyme capacity rather than reduced blood flow. The effect of cirrhosis is less than that reported in similar studies of high clearance oxidized drugs and this lends support to the concept that glucuronidation may be relatively spared in cirrhosis. A discrepancy between the systemic clearance and the hepatic clearance provides indirect support for extra-hepatic metabolism of morphine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2753069     DOI: 10.1007/bf00558076

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  28 in total

1.  The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function.

Authors:  J CAESAR; S SHALDON; L CHIANDUSSI; L GUEVARA; S SHERLOCK
Journal:  Clin Sci       Date:  1961-08       Impact factor: 6.124

2.  Effects of aging and liver disease on disposition of lorazepam.

Authors:  J W Kraus; P V Desmond; J P Marshall; R F Johnson; S Schenker; G R Wilkinson
Journal:  Clin Pharmacol Ther       Date:  1978-10       Impact factor: 6.875

3.  Presystemic glucuronidation of morphine in humans and rhesus monkeys: subcellular distribution of the UDP-glucuronyltransferase in the liver and intestine.

Authors:  G M Pacifici; C Bencini; A Rane
Journal:  Xenobiotica       Date:  1986-02       Impact factor: 1.908

4.  Enhanced bioavailability and decreased clearance of analgesics in patients with cirrhosis.

Authors:  E A Neal; P J Meffin; P B Gregory; T F Blaschke
Journal:  Gastroenterology       Date:  1979-07       Impact factor: 22.682

5.  Glucuronidation of paracetamol, morphine and 1-naphthol in the rat intestinal loop.

Authors:  D Josting; D Winne; K W Bock
Journal:  Biochem Pharmacol       Date:  1976-03-01       Impact factor: 5.858

6.  UDP-glucuronyltransferase in perfused rat liver and in microsomes - III. Effects of galactosamine and carbon tetrachloride on the glucuronidation of 1-naphthol and bilirubin.

Authors:  G Otani; M M Abou-El-Makarem; K W Bock
Journal:  Biochem Pharmacol       Date:  1976-06-01       Impact factor: 5.858

7.  Morphine analysis by high-performance liquid chromatography.

Authors:  J A Owen; D S Sitar
Journal:  J Chromatogr       Date:  1983-08-12

8.  Hepatic circulation in cirrhosis.

Authors:  P M Huet; J P Villeneuve; G Pomier-Layrargues; D Marleau
Journal:  Clin Gastroenterol       Date:  1985-01

9.  Pharmacokinetic interpretation of the enterohepatic recirculation and first-pass elimination of morphine in the rat.

Authors:  B E Dahlström; L K Paalzow
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

10.  Extrahepatic glucuronidation of morphine in the dog.

Authors:  E Jacqz; S Ward; R Johnson; S Schenker; J Gerkens; R A Branch
Journal:  Drug Metab Dispos       Date:  1986 Nov-Dec       Impact factor: 3.922

View more
  22 in total

Review 1.  Implications of opioid analgesia for medically complicated patients.

Authors:  Howard Smith; Patricia Bruckenthal
Journal:  Drugs Aging       Date:  2010-05       Impact factor: 3.923

Review 2.  Clinical pharmacokinetics in patients with liver disease.

Authors:  A J McLean; D J Morgan
Journal:  Clin Pharmacokinet       Date:  1991-07       Impact factor: 6.447

Review 3.  Pharmacokinetics of opioids in liver disease.

Authors:  I Tegeder; J Lötsch; G Geisslinger
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

Review 4.  Opioid metabolism.

Authors:  Howard S Smith
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

5.  Drug interactions: a primer for the gastroenterologist.

Authors:  Christina Teeter Doligalski; Angela Tong Logan; Andrew Silverman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-06

6.  The metabolism and bioavailability of morphine in patients with severe liver cirrhosis.

Authors:  J Hasselström; S Eriksson; A Persson; A Rane; J O Svensson; J Säwe
Journal:  Br J Clin Pharmacol       Date:  1990-03       Impact factor: 4.335

Review 7.  Fast track anesthesia for liver transplantation: Review of the current practice.

Authors:  Stephen Aniskevich; Sher-Lu Pai
Journal:  World J Hepatol       Date:  2015-09-18

Review 8.  Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.

Authors:  Roger K Verbeeck
Journal:  Eur J Clin Pharmacol       Date:  2008-09-02       Impact factor: 2.953

Review 9.  Role of supportive care for terminal stage hepatocellular carcinoma.

Authors:  Manoj Kumar; Dipanjan Panda
Journal:  J Clin Exp Hepatol       Date:  2014-03-31

10.  Plasma levels of morphine and morphine glucuronides in the treatment of cancer pain: relationship to renal function and route of administration.

Authors:  G M Peterson; C T Randall; J Paterson
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.